Literature DB >> 31768343

Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.

Meaghan S Dendy1, Johannes M Ludwig1,2, Stacey M Stein3,4, Hyun S Kim1,3,4.   

Abstract

Image-guided locoregional therapies (LRTs) have long been a vital part of treatment regimens for hepatocellular carcinoma (HCC). Ablation, chemoembolization, and radioembolization are examples of commonly used treatment techniques for HCC. This review describes the various methods utilized to treat HCC in the field of interventional oncology and also focuses on new and novel treatment concepts being developed in the field including the use of novel immunotherapy agents and combination therapy of LRTs with immunotherapy.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  HCC; Hepatocellular carcinoma; Immunotherapy; Locoregional therapy

Year:  2019        PMID： 31768343      PMCID： PMC6873025          DOI： 10.1159/000494843

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


  103 in total

1.  Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis.

Authors:  Yafei Zhang; Yiming Li; Hong Ji; Xin Zhao; Hongwei Lu
Journal:  Biosci Trends       Date:  2015-10       Impact factor: 2.400

2.  Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.

Authors:  Theodora A Potretzke; Timothy J Ziemlewicz; J Louis Hinshaw; Meghan G Lubner; Shane A Wells; Christopher L Brace; Parul Agarwal; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2016-03-24       Impact factor: 3.464

3.  The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.

Authors:  Francis Y Yao; Milan Kinkhabwala; Jeanne M LaBerge; Nathan M Bass; Robert Brown; Robert Kerlan; Alan Venook; Nancy L Ascher; Jean C Emond; John P Roberts
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

4.  Arming embolic beads with anti-VEGF antibodies and controlling their release using LbL technology.

Authors:  O S Sakr; S Berndt; G Carpentier; M Cuendet; O Jordan; G Borchard
Journal:  J Control Release       Date:  2016-01-11       Impact factor: 9.776

5.  Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

Authors:  Riccardo Lencioni; Laura Crocetti; Pasquale Petruzzi; Claudio Vignali; Elena Bozzi; Clotilde Della Pina; Irene Bargellini; Dania Cioni; Filippo Oliveri; Paolo De Simone; Carlo Bartolozzi; Maurizia Brunetto; Franco Filipponi
Journal:  J Hepatol       Date:  2008-04-24       Impact factor: 25.083

6.  Experimental transcatheter intraarterial infusion-occlusion chemotherapy.

Authors:  J H Anderson; C Gianturco; S Wallace
Journal:  Invest Radiol       Date:  1981 Nov-Dec       Impact factor: 6.016

7.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

8.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

9.  Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.

Authors:  Karen T Brown; Richard K Do; Mithat Gonen; Anne M Covey; George I Getrajdman; Constantinos T Sofocleous; William R Jarnagin; Michael I D'Angelica; Peter J Allen; Joseph P Erinjeri; Lynn A Brody; Gerald P O'Neill; Kristian N Johnson; Alessandra R Garcia; Christopher Beattie; Binsheng Zhao; Stephen B Solomon; Lawrence H Schwartz; Ronald DeMatteo; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2016-02-01       Impact factor: 44.544

Review 10.  Microwave ablation of hepatocellular carcinoma.

Authors:  Ping Liang; Yang Wang
Journal:  Oncology       Date:  2007-12-13       Impact factor: 2.935
View more
  15 in total

Review 1.  Therapy in Advanced Hepatocellular Carcinoma.

Authors:  Hanna Javan; Farshid Dayyani; Nadine Abi-Jaoudeh
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 2.  Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer.

Authors:  Matthew R Woeste; Anne E Geller; Robert C G Martin; Hiram C Polk
Journal:  Ann Surg Oncol       Date:  2021-01-03       Impact factor: 5.344

3.  Bronchial Artery Chemoembolization With Radiopaque Doxorubicin Eluding Beads in Patients With Malignant Hemoptysis from Metastatic Lung Cancer.

Authors:  Nariman Nezami; Christos Georgiades; Kelvin K Hong; Ji Buethe
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

4.  The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma.

Authors:  Angela Dalia Ricci; Alessandro Rizzo; Chiara Bonucci; Simona Tavolari; Andrea Palloni; Giorgio Frega; Veronica Mollica; Nastassja Tober; Elena Mazzotta; Cristina Felicani; Carla Serra; Giovanni Brandi
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.

Authors:  Anil C Anand; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2021-04-27

Review 6.  Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?

Authors:  Ti Zhang; Philippe Merle; Huaqi Wang; Haitao Zhao; Masatoshi Kudo
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 8.265

7.  Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma.

Authors:  Aritz Lasarte-Cia; Teresa Lozano; David Cano; Celia Martín-Otal; Flor Navarro; Marta Gorraiz; Noelia Casares; Isabel Vivas; Juan José Lasarte
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

8.  Subsequent Ultrasound Vascular Targeting Therapy of Hepatocellular Carcinoma Improves the Treatment Efficacy.

Authors:  Laith R Sultan; Mrigendra B Karmacharya; Stephen J Hunt; Andrew K W Wood; Chandra M Sehgal
Journal:  Biology (Basel)       Date:  2021-01-22

Review 9.  Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes.

Authors:  Yang Xuan; Meng Guan; Shubiao Zhang
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556

Review 10.  Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update.

Authors:  Sirish A Kishore; Raazi Bajwa; David C Madoff
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.